Yahoo India Web Search

Sign In

Search results

  1. alexion.com › our-company › leadershipFred Chereau - Alexion

    Fred Chereau is Senior Vice President, Strategy and Business Development of Alexion, AstraZeneca Rare Disease. About Fred. Fred brings close to 30 years of biotech, pharmaceutical, and medical device experience to Alexion, where he oversees strategy and business development activities.

  2. www.linkedin.com › in › fredchereauFrederic "Fred" Chereau - Alexion Pharmaceuticals, Inc ...

    View Frederic "Fred" Chereau’s profile on LinkedIn, a professional community of 1 billion members. Experience: Alexion Pharmaceuticals, Inc. · Location: Boston · 500+ connections on...

    • 500+
    • Boston, Massachusetts, United States
    • Alexion Pharmaceuticals, Inc.

  3. www.astrazeneca-us.com › media › press-releasesAlexion, AstraZeneca Rare Disease to Acquire LogicBio ...

    Oct 3, 2022 · Fred Chereau, President and Chief Executive Officer, LogicBio, said: “We are excited about the opportunity to bring our science and expertise in genetic medicine to Alexion, which shares our commitment to discovering treatments for rare conditions and improving the lives of patients.

  4. www.prnewswire.com › news-releases › alexion-astraAlexion, AstraZeneca Rare Disease to Acquire LogicBio ...

    Oct 3, 2022 · Fred Chereau, President and Chief Executive Officer, LogicBio, said: "We are excited about the opportunity to bring our science and expertise in genetic medicine to Alexion, which shares our...

  5. www.biopharma-reporter.com › Article › 2022/10/04AstraZeneca’s Alexion acquires genomic medicine company

    Oct 4, 2022 · Fred Chereau, President and Chief Executive Officer, LogicBio, added: “We are excited about the opportunity to bring our science and expertise in genetic medicine to Alexion, which shares our commitment to discovering treatments for rare conditions and improving the lives of patients.

  6. www.linkedin.com › posts › fredchereau_alexion-astraFrederic Chereau on LinkedIn: Alexion, AstraZeneca Rare ...

    Frederic Chereau. SVP, Strategy and Business Development at Alexion. 1mo. Very exciting to think we have a chance to shape medicine with a revolutionary approach to science and bring new drugs...

  7. People also ask

  8. www.genengnews.com › topics › genome-editingLogicBio Acquired by Alexion, AstraZeneca Rare Disease

    Oct 3, 2022 · “We are excited about the opportunity to bring our science and expertise in genetic medicine to Alexion, which shares our commitment to discovering treatments for rare conditions and improving the...